Abstract
Remarkable progress has been made in our understanding of the mechanisms by which the immune system responds to challenge by invading pathogens. Driven by urgent clinical problems, including the pandemic caused by human immunodeficiency virus type 1 (HIV-1) (1,2), these basic advances are starting to yield rewards in the treatment of human disease. Despite these gains, many fundamental questions remain unanswered, including many related to the factors that govern reconstitution of the immune system following its destruction in the setting of human disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McCune JM. HIV-1: the infective process in vivo. Cell 1991; 64: 351–63.
Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328: 327–35.
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853–60.
Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, et al. Positive effects of cornbined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112–6.
Gorochov G, Neumann AU, Kereveur A, Parizot C, Li T, Katlama C, et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998; 4: 215–21.
Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351: 1682–6.
Komanduri KV, Viswanathan MN, Wieder ED, Schmidt DK, Bredt BM, Jacobson MA, McCune JM. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998; 4: 953–6.
Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St. Clair M, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis 1998; 178: 70–9.
Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3: 533–40.
Jacobson MA, Zegans M, Pavan PR, O’Donnell JJ, Sattler F, Rao N, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349: 1443–5.
Miller JFAP. Immunological function of the thymus. Lancet 1961; ii:748–9.
Miller JFAP. Immunological significance of the thymus of the adult mouse. Nature 1962; 195: 1318–9.
Gowans JL, McGregor DD, Cowen DM, Ford CE. Initiation of immune responses by small lymphocytes. Nature 1962; 196: 651–5.
Miller JF, Mitchell GF. The thymus and the precursors of antigen reactive cells. Nature 1967; 216: 659–63.
Brummendorf TH, Dragowska W, Zijlmans J, Thornbury G, Lansdorp PM. Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver cells. J Exp Med 1998; 188: 1117–24.
Morrison SJ, Wright DE, Cheshier SH, Weissman IL. Hematopoietic stem cells: challenges to expectations. Curr Opin Immunol 1997; 9: 216–21.
Haynes BF, Heinly CS. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med 1995; 181: 1445–58.
Gale RP. Development of the immune system in the human fetal liver. Thymus 1987; 10: 45–52.
Schmitt C, Ktorza S, Sarun S, Verpilleux MP, Blanc C, Deugnier MA, et al. CD34-positive early stages of human T-cell differentiation. Leuk Lymph 1995; 17: 43–50.
Spits H. Early stages in human and mouse T-cell development. Curr Opin Immunol 1994; 6: 212–21.
Scollay R, Smith J, Stauffer V. Dynamics of early T cells: prothymocyte migration and proliferation in the adult mouse thymus. Immunol Rev 1986; 91: 129–57.
Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 1992; 89: 2804–8.
Galy A, Verma S, Bârcena A, Spits H. Precursors of CD3+ CD4+ CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J Exp Med 1993; 178: 391–401.
Res P, Martinez-Caceres E, Cristina Jaleco A, Staal F, Noteboom E, Weijer K, Spits H. CD34+ CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood 1996; 87: 5196–206.
Barcena A, Galy AH, Punnonen J, Muench MO, Schols D, Roncarolo MG, et al. Lymphoid and myeloid differentiation of fetal liver CD34+-lineage cells in human thymic organ culture. J Exp Med 1994; 180: 123–32.
Blom B, Res P, Noteboom E, Weijer K, Spits H. Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage. J Immunol 1997; 158: 3571–7.
Ramiro AR, Trigueros C, Marquez C, San Millan JL, Toribio ML. Regulation of pre-T cell receptor (pT alpha-TCR beta) gene expression during human thymic development. J Exp Med 1996; 184: 519–30.
Fehling HJ, von Boehmer H. Early alpha beta T cell development in the thymus of normal and genetically altered mice. Curr Opin Immunol 1997; 9: 263–75.
Kong F, Chen CH, Cooper MD. Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation. Immunity 1998; 8: 97–104.
McCune JM. Development and applications of the SCID-hu mouse model. Semin Immunol 1996; 8: 187–96.
Weissman IL. Thymus cell maturation. Studies on the origin of cortisone-resistant thymic lymphocytes. J Exp Med 1973; 137: 504–10.
Fathman CG, Small M, Herzenberg LA, Weissman IL. Thymus cell maturation. II. Differentiation of three “mature” subclasses in vivo. Cell Immunol 1975; 15: 109–28.
Dunon D, Imhof BA. Mechanisms of thymus homing. Blood 1993; 81: 1–8.
Wu L, Li C, Shortman K. Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med 1996; 184: 903–11.
Galy AHM, Cen D, Travis M, Chen S, Chen BR. Delination of T-progenitor activity within the CD34+ compartment of adult bone marrow. Blood 1995; 85: 2770–78.
Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995; 3: 459–73.
Miller JS, Verfaillie C, McGlave P. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture. Blood 1992; 69: 2182–7.
Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med 1994; 180: 569–76.
Zúniga-Pflücker JC, Lenardo MJ. Regulation of thymocyte development from immature progenitors. Curr Opin Immunol 1996; 8: 215–24.
Wu L, Scollay R, Egerton M, Pearse M, Spangrude GJ, Shortman K. CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature 1991; 349: 71–4.
Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol 1992; 149: 2281–5.
Godfrey DI, Kennedy J, Suda T, Zlotnik A. A developmental pathway involving four phenotypically and functionally distinct sets of CD3- CD4- CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 1993; 150: 4244–52.
Godfrey DI, Kennedy J, Mombaerts P, Tonegawa S, Zlotnik A. Onset of TCR beta gene rearrangement and role of TCR beta expression during CD3- CD4- CD8- thymocyte differentiation. J Immunol 1994; 152: 4783–92.
Wurch A, Biro J, Potocnik A, Falk I, Mossmann H, Eichmann K. Requirement of CD3 complex-associated signaling functions for expression of rearranged T cell recepter beta VDJ genes in early thymic development. J Exp Med 1998; 188: 1669–78.
Saint-Ruf C, Ungewiss K, Groettrup M, Bruno L, Fehling HJ, von Boehmer H. Analysis and expression of a cloned pre-T cell receptor gene. Science 1994; 266: 1208–12.
Owen MJ, Venkitaraman AR. Signalling in lymphocyte development. Curr Opin Immunol 1996; 8: 191–8.
Trigueros C, Ramiro AR, Carrasco YR, de Yebenes VG, Albar JP, Tiribio ML. Identification of a late stage of small noncycling pT-alpha negative T cells as immediate precursors of T cell receptor alpha/beta thymocytes. J Exp Med 1998; 188: 1401–12.
Kraft DL, Weissman IL, Waller EK. Differentiation of CD3–4–8– human fetal thymocytes in vivo: characterization of a CD3–4+ 8– intermediate. J Exp Med 1993; 178: 265 – 77.
Guidos CJ. Positive selection of CD4+ and CD8+ T cells. Curr Opin Immunol 1996; 8: 225–32.
Vanhecke D, Leclercq G, Plum J, Vandekerckhove B. Characterization of distinct stages during the differentiation of human CD69+ CD3+ thymocytes and identification of thymic emigrants. J Immunol 1995; 155: 1862–72.
Vanhecke D, Verhasselt B, Debacker V, Leclercq G, Plum J, Vandekerckhove B. Differentiation to T helper cells in the thymus. Gradual acquisition of T helper cell function by CD3+ CD4+ cells. J Immunol 1995; 155: 4711–8.
Res P, Blom B, Hori T, Weijer K, Spits H. Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development. Journal of Exp Med 1997; 185: 141–51.
Benoist C, Mathis D. Positive selection of T cells: fastidious or promiscuous? Curr Opin Immunol 1997; 9: 245–9.
Marrack P, Kappler J. Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol 1997; 9: 250–5.
Lucas B, Germain RN. T-cell repertoire: political correctness in the immune system. Curr Biol 1996; 6: 783–7.
Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, Tonegawa S. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994; 76: 651–63.
Sebzda E, Wallace VA, Mayer J, Yeung RS, Mak TW, Ohashi PS. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 1994; 263: 1615–8.
Hogquist KA, Jameson CS, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 17–27.
Hogquist KA, Tomlinson AJ, Kieper WC, McGargill MA, Hart MC, Naylor S, Jameson SC. Identification of a naturally occurring ligand for thymic positive selection. Immunity 1997; 6: 389–99.
Pawlowski TJ, Singleton MD, Loh DY, Berg R, Staerz UD. Permissive recognition during positive selection. Eur J Immunol 1996; 26: 851–7.
Nakano N, Rooke R, Benoist C, Mathis D. Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science 1997; 275: 678–83.
Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 1998; 8: 403–11.
Janeway CA, Jr. A tale of two T cells. Immunity 1998; 8: 391–4.
van Meerwijk JPM, Marguerat S, Lees RK, Germain RN, Fowlkes BJ, MacDonald HR. Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med 1997; 185: 377–84.
Simpson E, Takacs K, Altmann DM. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules. Thymus 1994; 23: 1–13.
Abe R, Vacchio MS, Fox B, Hodes RJ. Preferential expression of the T-cell receptor V beta 3 gene by Mlsc reactive T cells. Nature 1988; 335: 827–30.
Choi YW, Herman A, DiGiusto D, Wade T, Marrack P, Kappler J. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature 1990; 346: 471–3.
Choi Y, Kappler JW, Marrack P. A superantigen encoded in the open reading frame of the 3’ long terminal repeat of mouse mammary tumour virus. Nature 1991; 350: 203–7.
Kappler JW, Staerz U, White J, Marrack PC. Self-tolerance eliminates T cells specific for Mlsmodified products of the major histocompatibility complex. Nature 1988; 332: 35–40.
Pullen AM, Marrack P, Kappler JW. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 1988; 335: 796–801.
Jenkinson EJ, Anderson G, Owen JJT. Studies on T-cell maturation on defined thymic stromal cells in vitro. J Exp Med 1992; 176: 845–53.
Baccala R, Vandekerckhove BA, Jones D, Kono DH, Roncarolo MG, Theofilopoulos AN. Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model. J Exp Med 1993; 177: 1481–5.
Waller EK, Sen-Majumdar A, Kamel OW, Hansteen GA, Schick MR, Weissman IL. Human T-cell development in SCID-hu mice: staphylococcal enterotoxins induce specific clonal deletions, proliferation, and anergy. Blood 1992; 80: 3144–56.
Komanduri KV, Salha MD, Sékaly RP, McCune JM. Superantigen-mediated deletion of specific T cell receptor V beta subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1. J Immunol 1997; 158: 544–9.
Owen JJ, Moore NC. Thymocyte-stromal-cell interactions and T-cell selection. Immunol Today 1995; 16: 336–8.
Sprent J, Webb SR. Intrathymic and extrathymic clonal deletion of T cells. Cuff Opin Immunol 1995; 7: 196–205.
Vandekerckhove BA, Namikawa R, Bacchetta R, Roncarolo MG. Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus. J Exp Med 1992; 175: 1033–43.
Klein L, Klein T, Rüther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998; 188: 5–16.
Pugliese A, Zeller M, Fernandez JA, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997; 15: 293–7.
Vafiadis P, Bennet ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997; 15: 289–92.
Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 1997; 159: 3109–12.
Heath V, Mason D, Ramirez F, Seddon B. Homeostatic mechanisms in the control of autoimmunity. Semin Immunol 1997; 9: 375–80.
Anderson G, Moore NC, Owen JJ, Jenkinson EJ. Cellular interactions in thymocyte development. Annu Rev Immunol 1996; 14: 73–99.
Boyd RL, Tucek CL, Godfrey DI, Izon DJ, Wilson TJ, Davidson NJ, et al. The thymic microenvironment. Immunol Today 1993; 14: 445–59.
Denning SM, Kurtzberg J, Le PT, Tuck DT, Singer KH, Haynes BE Human thymic epithelial cells directly induce activation of autologous immature thymocytes. Proc Natl Acad Sci USA 1988; 85: 3125–9.
Berkowitz RD, Alexander S, Bare C, Linquist-Stepps V, Bogan M, Moreno ME, et al. CCR5 and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol 1998; 72: 10108–17.
Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988; 333: 571–3.
Komschlies KL, Grzegorzewski KJ, Wiltrout RH. Diverse immunological and hematological effects of interleukin 7: implications for clinical application. J Leuk Biol 1995; 58: 623–33.
Sudo T, Nishikawa S, Ohno N, Akiyama N, Tamakoshi M, Yoshida H. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci USA 1993; 90: 9125–9.
Maraskovsky E, O’Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A. Bc1–2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell 1997; 89: 1011–9.
Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL. Bc1–2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997; 89: 1033–41.
Schmitt C, Ktorza S, Sarun S, Blanc C, De Jong R, Debre P. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood 1993; 82: 3675–85.
Varas A, Vicente A, Sacedón R, Zapata AG. Interleukin-7 influences the development of thymic dendritic cells. Blood 1998; 92: 93–100.
Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996; 88: 1887–94.
Napolitano LA, Grant RM, Schmidt DK, De Rosa SC, Herzenberg LA, Deeks SG et al. Circulating interleukin-7 levels are correlated with CD4+ lymphopenia and viral load in HIV-1 infected individuals: implications for disease progression. Nature Med 2001; 7: 73–9.
Fry TJ, Connick E, Landay A, Lederman MM, Wood LV, Yarchoan R, Mackall CL. A potential role for IL-7 in T-cell homeostasis in HIV-infected patients. 7th Conf on Retrovirus & Opportunistic Infections presented at San Francisco, 2000.
Lyman SD. Biology of flt3 ligand and receptor. Int J Hematol 1995; 62: 63–73.
Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157–67.
Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998; 91: 1101–34.
Rodewald HR, Kretzschmar K, Swat W, Takeda S. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 1995; 3: 313–9.
Rodewald HR, Ogawa M, Haller C, Waskow C, DiSanto JP. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity 1997; 6: 265–72.
Moore TA, Zlotnik A. Differential effects of Flk-2/Flt-3 ligand and stem cell factor on murine thymic progenitor cells. J Immunol 1997; 158: 4187–92.
Frearson JA, Alexander DR. Protein tyrosine phosphatases in T-cell development, apoptosis and signalling. Immunol Today 1996; 17: 385–91.
Schmedt C, Saijo K, Niidome T, Kuhn R, Aizawa S, Tarakhovsky A. Csk controls antigen receptor-mediated development and selection of T-lineage cells. Nature 1998; 394: 901–4.
Shao H, Kono DH, Chen L-Y, Rubin EM, Kaye J. Induction of the early growth response (Egr) family of transcription factors during thymic selection. J Exp Med 1997; 185: 731–44.
Ting C-N, Olson MC, Barton KP, Leiden JM. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 1996; 384: 474–8.
Williams O, Norton T, Halligey M, Kioussis D, Brady HJM. The action of bax and bc1–2 on T cell selection. J Exp Med 1998; 188: 1125–33.
Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, et al. Impaired negative selection of T cells in Hodgkin’s disease antigen CD30-deficient mice. Cell 1996; 84: 551–62.
Bell EB, Sparshott SM, Bunce C. CD4+ T cell memory, CD45R subsets and the persistence of antigen-a unifying concept. Immunol Today 1998; 19: 60–4.
Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60–6.
Rothbard JB, Gefter ML. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 1991; 9: 527–65.
Bretscher P. The two-signal model of lymphocyte activation twenty-one years later. Immunol Today 1992; 13: 74–9.
Croft M, Dubey C. Accessory molecule and costimulation requirements for CD4 T cell response. Crit Rev Immunol 1997; 17: 89–118.
Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996; 273: 104–6.
Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997; 158: 5676.
McLeod JD, Walker LSK, Patel YI, Boulougouris G, Sansom DM. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J Immunol 1998; 160: 2072–79.
Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272: 54–60.
Farber DL. Differential TCR signaling and the generation of memory T cells. J Immunol 1998; 160: 535–9.
Sprent J, Tough DF. Lymphocyte life-span and memory. Science 1994; 265: 1395–400.
Farber DL, Acuto O, Bottomly K. Differential T cell receptor-mediated signaling in naive and memory CD4 T cells. Eur J Immunol 1997; 27: 2094–101.
Busch DH, Pilip I, Pamer EG. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J Exp Med 1998; 188: 61–70.
Sourdive DJ, Murali-Krishna K, Altman JD, Zajac AJ, Whitmire JK, Pannetier C, et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med 1998; 188: 71–82.
Ogg GS, McMichael AJ. HLA-peptide tetrameric complexes. Curr Opin Immunol 1998; 10: 393–6.
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708–12.
Michie CA, McLean A, Alcock C, Beverley PC. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992; 360: 264–5.
Bunce C, Bell EB. CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J Exp Med 1997; 185: 767–76.
Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995; 95: 2061–6.
Richards D, Chapman MD, Sasama J, Lee TH, Kemeny DM. Immune memory in CD4+ CD45RA+ T cells. Immunology 1997; 91: 331–9.
Abbas A, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787–93.
Romagnani S. The Thl/Th2 paradigm. Immunol Today 1997; 18: 263–6.
Clerici M, Shearer G. The Thl-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15: 575–81.
Mitra DK, De Rosa SC, Luke A, Balamurugan A, Khaitan BK, Tung J, et al. Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. Int Immunol 1999; 11: 1801–10.
Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999; 5: 677–85.
Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393: 474–8.
Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-Tcell responses is mediated by CD40 signalling. Nature 1998; 393: 478–80.
Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions. Nature 1998; 393: 480–3.
Mackey MF, Gunn JR, Maliszewsky C, Kikutani H, Noelle RJ, Barth RJ Jr. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 1998; 161: 2094–8.
Lord GM, Matarese G, Howard LK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897–901.
Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191–3.
Adleman LM, Wofsy D. T cell homeostasis: implications in HIV infection. J AIDS 1993; 6: 144–52.
Margolick JB, Donnenberg AD. T-cell homeostasis in HIV-1 infection. Semin Immunol 1997; 9: 381–8.
Mehr R, Perelson AS, Fridkis-Hareli M, Globerson A. Regulatory feedback pathways in the thymus. Immunol Today 1997; 18: 581–5.
Mehr R, Perelson AS. Blind T-cell homeostasis and the CD4/CD8 ratio in the thymus and peripheral blood. J AIDS Hum Retrovirol 1997; 14: 387–98.
Bell EB, Sparshott SM. The peripheral T-cell pool: regulation by non-antigen induced proliferation? Semin Immunol 1997; 9: 347–53.
Tanchot C, Rocha B. The peripheral T cell repertoire: independent homeostatic regulation of virgin and activated CD8+ T cell pools. Eur J Immunol 1995; 25: 2127–36.
Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997; 157: 61–72.
Mackall CL, Hakim FT, Gress RE. Restoration of T-cell homeostasis after T-cell depletion. Semin Immunol 1997; 9: 339–46.
Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993; 82: 2585–94.
Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156: 4609–16.
Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ. Determination of antigen-specific memory/effector CD4+T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997; 99: 1739–50.
McCune JM. Thymic function in HIV-1 disease. Semin Immunol 1997; 9 (6): 397–404.
Steinmann GG. Changes in the human thymus during aging. Curr Top Pathol 1986; 75: 43–88.
Moore AV, Korobkin M, Olanow W, Heaston DK, Ram PC, Dunnick NR, Silverman PM. Age-related changes in the thymus gland: CT-pathologic correlation. AJR 1983; 141: 241–6.
Francis IR, Glazer GM, Brookstein FL, Gross BH. The thymus: reexamination of age-related changes in size and shape. Am J Roentgenol 1985; 145: 249–54.
Dixon AK, Hilton CJ, Williams GT. Computed tomography and histological correlation of the thymic remnant. Clin Radiol 1981; 32: 255–7.
Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369–80.
Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev 1997; 157: 73–8.
Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471–90.
Choyke PL, Zeman RK, Gootenberg JE, Greenberg JN, Hoffer F, Frank JA. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. Am J Roentgenol 1987; 149: 269–72.
Small EJ, Venook AP, Damon LE. Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease. Cancer 1993; 72: 905–8.
Miniero R, Busca A, Leonardo E, Mossetti C, Machado D, Vassallo E, Madon E. Rebound thymic hyperplasia following high dose chemotherapy and allogeneic BMT. Bone Marrow Transplant 1993; 11: 67–70.
Chertoff J, Barth RA, Dickerman JD. Rebound thymic hyperplasia five years after chemotherapy for Wilms’ tumor. Pediatr Radiol 1991; 21: 596–7.
Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143–9.
Roederer M, De Rosa SC, Watanabe N, Herzenberg LA. Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation. Semin Immunol 1997; 9: 389–96.
Watanabe N, De Rosa SC, Cmelak A, Hoppe R, Herzenberg LA, Roederer M. Long-term depletion of naive T cells in patients treated for Hodgkin’s disease. Blood 1997; 90: 3662–72.
Beagley KW, Husband AJ. Intraepithelial lymphocytes: origins, distribution, and function. Crit Rev Immunol 1998; 18: 237–54.
Clegg CH, Rulffes JT, Wallace PM, Haugen HS. Regulation of an extrathymic T-cell development pathway by oncostatin M. Nature 1996; 384: 261–3.
Garcia-Ojeda ME, Dejbakhsh-Jones S, Weissman IL, Strober S. An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation. J Exp Med 1998; 187: 1813–23.
Heitger A, Neu N, Kern H, Panzer-Grümayer ER, Greinix H, Nachbaur D, et al. Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997; 90: 850–7.
Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89: 3700–7.
Hellerstein MK, McCune JM. T cell turnover in HIV-1 disease. Immunity 1997; 7: 583–9.
McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998; 101: 2301–8.
Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J Clin Invest 1995; 95: 2054–60.
Macallan DC, Fullerton CA, Neese RA, Haddock K, Park SS, Hellerstein MK. Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc Natl Acad Sci USA 1998; 95: 708–13.
Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999; 5: 83–9.
McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, et al. Factors influencing T-cell turnover in HIV-1-seropositive patients. J Clin Invest 2000; 105: R1–8.
Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science 1999; 286: 958–61.
Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological, and cornparative analyses. Adv Immunol 1994; 56: 27–150.
Lewis SM, Wu GE. The origins of V(D)J recombination. Cell 1997; 88: 159–62.
Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396: 690–5.
Poulin JF, Viswanathan MN, Harris JM, Komanduri KV, Wieder E, Ringuette N, et al. Direct evidence for thymic function in adult humans. J Exp Med 1999; 190: 479–86.
Zhang L, Lewin SR, Markowitz M, Lin HH, Skulsky E, Karanicolas R, et al. Measuring recent thymic emigrants in blood of normal and HIV-1—infected individuals before and after effective therapy. J Exp Med 1999; 190: 725–32.
Hatzakis A, Touloumi G, Karanicolas R, Karafoulidou A, Mandalaki T, Anastassopopoulou C, et al. Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet 2000; 355: 599–604.
Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, et al. Assessment of thymic output in adults after haematopoietic stem—cell transplant and prediction of T cell reconstitution. Lancet 2000; 355: 1875–81.
Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM. HIV-1—induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 1995; 2: 25–36.
Jenkins M, Hanley MB, Moreno MB, Wieder E, McCune JM. Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood 1998; 91: 2672–8.
McCune JM. Animal models of HIV-1 disease. Science 1997; 278: 2141–2.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Komanduri, K.V., McCune, J.M. (2001). Development and Reconstitution of T-Lymphoid Immunity. In: Pantaleo, G., Walker, B.D. (eds) Retroviral Immunology. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-110-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-59259-110-7_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-128-8
Online ISBN: 978-1-59259-110-7
eBook Packages: Springer Book Archive